LONDON (ShareCast) - (Sharecast News) - Advanced Medical Solutions said on Monday that it expects first-half revenue of about £115.2m, up from £110.8m a year earlier, despite some orders slipping into early July and de-stocking linked to the expansion of direct sales in Europe.
The AIM-traded firm said the period also faced a strong comparator after order phasing from a key strategic partner boosted the Advance Closure division in the first half of 2025.

The group said the integration of Peters Surgical and Syntacoll remained on track and reiterated that full-year 2026 EBITDA was expected to meet current market forecasts.

Chief executive Chris Meredith said AMS remained confident in its long-term prospects, supported by its strengthened product portfolio and pipeline of opportunities.

At 1400 BST, shares in Advanced Medical Solutions Group were up 0.4% at 280.12p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE